Miller Mary sold $1K of ACRV
Miller Mary (Chief Legal Officer) sold 573 shares of Acrivon Therapeutics, Inc. (ACRV) at $1.76 on 2026-07-21.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale details (573 shares, $1.7600/share, $1,008.48 total) by the Chief Legal Officer.
Market read
Traders may note insider selling, but the disclosed transaction appears routine and low-dollar, limiting actionable impact.
What to watch
Insider sales can be non-informational; without context on total insider holdings, vesting schedules, or prior sales cadence, the signal is weak.
Background
The article is an SEC Form 4 insider transaction disclosure for Acrivon Therapeutics, Inc.
Ticker impact
Acrivon Therapeutics insider sale: Chief Legal Officer Miller Mary sold 573 shares at $1.7600 on 2026-07-21, per Form 4.
Low likelihood of a sustained price move based solely on this Form 4 sale.
The filing is a standard S (open-market sale) transaction, with no 10b5-1 plan and no accompanying fundamental catalyst disclosed in the text.
Market effects
No sector-wide read-through; this is company-specific insider transaction data.
None indicated.
None indicated.
Counterpoint
No 10b5-1 plan is noted, but the sale size is small, so it may reflect liquidity or diversification rather than bearish conviction.
Key entities
- issuerAcrivon Therapeutics, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderMiller Mary
Chief Legal Officer who sold 573 shares.
